This competitive program seeks to encourage organizations to submit grant applications for independent medical education initiatives that will result in the measurable improvement of the medical and scientific understanding of emerging treatment options for patients with Hemophilia.
Projects that will be considered for Pfizer support will focus on:
• Educating on the evolving treatment landscape (i.e. genetic medicine, rebalancing strategies) for hemophilia to improve the understanding of these novel approaches and their potential clinical applicability.
• Discussing shared decision making (SDM) and practical approaches on how SDM can be incorporated into hemophilia patient care1
• Educating on the benefits of omnichannel healthcare strategies which can provide a seamless, personalized service and patient care experience2
• Sharing knowledge and best practices (i.e. staff training, SOP, follow-up care) on how Hemophilia Treatment Centers (HTCs) and multidisciplinary team are preparing for novel therapies in development
• Advancing patient education on the evolving hemophilia treatment landscape and improving patient’s empowerment and ability to make informed decisions about their care
Applications will be accepted on a rolling basis through September but reviewed based on the timelines listed in the Key Dates section.
Review Dates: July 31, 2034; Sep. 30, 2024
Geographic Scope: Global (excluding United States)
• Only organizations are eligible to receive grants, not individuals or medical practice groups. • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; patient advocacy groups; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.
Sponsor Institute/Organizations: Pfizer Inc.
Address: 66 Hudson Boulevard East New York, NY 10001-2192 USA
Sep 30, 2024
$100,000
Affiliation: Pfizer Inc.
Address: 66 Hudson Boulevard East New York, NY 10001-2192 USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.